期刊文献+

姑息性手术治疗Ⅳ期右半结肠癌的疗效及预后不良危险因素分析 被引量:1

Effect of palliative surgery in the treatment of stage Ⅳ right-sided colon cancer and analysis of risk factors for poor prognosis
暂未订购
导出
摘要 目的探讨Ⅳ期右半结肠癌患者接受姑息性手术的疗效,并分析预后不良的危险因素。方法纳入2013年1月至2016年6月于本院接受姑息性手术的97例Ⅳ期右半结肠癌患者为研究对象,术后随访3年,观察手术治疗效果及患者生存情况,采用Cox回归模型分析观察组预后不良的危险因素。结果 97例患者均手术成功,未见30d内死亡患者,术后45例出现并发症。随访期间79例死亡,患者总体中位生存时间11.0个月,1年、2年、3年累积生存率分别为45.4%、24.7%、18.8%。T_4分期、N_2分期、术前梗阻、伴腹膜种植、术前癌胚抗原升高是患者预后不良的危险因素(OR=2.535、2.111、3.474、2.667、4.685,均P<0.05),术后接受靶向治疗是患者预后的保护因素(OR=-0.497,P<0.05)。结论姑息性手术对治疗Ⅳ期右半结肠癌有一定价值;T_4分期、N_2分期、术前梗阻、伴腹膜种植、术前癌胚抗原升高是患者预后不良的危险因素,术后接受靶向治疗是患者预后的保护因素。 Objective To investigate the clinical effect of palliative surgery for patients with stage Ⅳ right-sided colon cancer, and to analyze the risk factors for poor prognosis. Methods 97 patients with stage Ⅳ right-sided colon cancer treated with palliative surgery during January 2013 to June 2016 were selected as the research subjects and were followed-up of 3 years. The clinical effect of the surgery and cumulative survival rate were recorded. Risk factors for poor prognosis were analyzed using Cox regression. Results Surgeries for the 97 patients were successful. No patient died within 30 days of surgery. 45 patients developed complications. 79 cases died during following-up. The overall median survival time was 11.0 months, and the cumulative survival rates were 45.4%, 24.7% and 18.8% at 1, 2 and 3 years, respectively. Stage T_4, stage N_2, preoperative obstruction, peritoneal implantation, and high levels of preoperative carcinoembryonic antigen were risk factors of poor prognosis(OR = 2.535, 2.111, 3.474, 2.667, and 4.685, respectively, all P〈0.05). Postoperative targeted therapy was the protective factor for prognosis(OR =-0.497, P〈0.05). Conclusion Palliative surgery is valuable for the treatment of stage Ⅳ right-sided colon cancer. Stage T_4, stage N_2, preoperative obstruction, peritoneal implantation, and high levels of preoperative carcinoembryonic antigen are risk factors for poor prognosis. Postoperative targeted therapy was the protective factor for prognosis.
作者 丁海滨 Ding Haibin(Department of Thoracic Surgery,Tianmen First People's Hospital,Tianmen,Hubei,431700,China)
出处 《结直肠肛门外科》 2018年第4期355-359,共5页 Journal of Colorectal & Anal Surgery
关键词 Ⅳ期右半结肠癌 姑息切除术 预后 危险因素 stage IV right-sided colon cancer palliative surgery prognosis risk factors
  • 相关文献

参考文献10

二级参考文献95

  • 1Virginia,Pinol,,MD,Antoni,Castells,,MD,Montserrat,Andreu,,MD,许峰(译),祝学光(校).新版Bethesda指南、微卫星不稳定性检测和免疫组化检查诊断遗传性非息肉性结直肠癌的准确性[J].美国医学会杂志(中文版),2005,24(6):373-373. 被引量:24
  • 2樊友本,程英升,陈尼维,许惠敏,杨喆,汪昱,郑起,黄玉耀,冯昌宁.支架植入治疗左半结肠直肠癌所致的急性梗阻[J].外科理论与实践,2006,11(6):496-499. 被引量:4
  • 3Cassidy J, Clarke S, Diaz-Rubio E, et al. XELOX vs FOLFOX- 4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results? [J]. Br J Cancer, 2011, 105(1) :58-64.
  • 4Haydon A. Adjuvant chemotherapy in colon cancer: what is the evidence? [J]. Intern Med J, 2003.33: 119-124.
  • 5Rocha J A. Bevacizumab in combination with irinotecan, 5- fluorouracil and leucovorin given as first-line treatment of metastatic eolorectal cancer [J]. Anticancer Drugs, 2011,22 (Suppl 2) : S9-S13.
  • 6Doi T, Boku N, Kato K, et al. Phase Ⅰ/Ⅱ Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer [ J ]. Jpn J Clin Oncol, 2010,40 (10) : 913- 920.
  • 7Edge SB, Byrd DR, Comptan CC, et al. AJCC Cancer Staging Manual 7th Edition[M]. Springer; 2010.
  • 8Washington MK, Berlin J, Branton PA, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum[J]. Arch Pathol Lab Med, 2008,132: 1182-1193.
  • 9Wichmann MW, Muller C, Meyer G. et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer[J]. Arch Surg, 2002,137:206-210.
  • 10Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit [J]. Am J Surg Pathol, 2002,26 : 350-357.

共引文献121

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部